- Patent Title: Beta-hydroxybutyrate encapsulated PLGA nanoparticle compositions
-
Application No.: US16655125Application Date: 2019-10-16
-
Publication No.: US11266617B2Publication Date: 2022-03-08
- Inventor: Omer Yilmaz , Chia-Wei Cheng , George Eng , Fang Wang
- Applicant: Massachusetts Institute of Technology
- Applicant Address: US MA Cambridge
- Assignee: Massachusetts Institute of Technology
- Current Assignee: Massachusetts Institute of Technology
- Current Assignee Address: US MA Cambridge
- Agency: Hamilton, Brook, Smith & Reynolds, P.C.
- Main IPC: A61K31/194
- IPC: A61K31/194 ; A61K9/16 ; A61K9/51 ; B82Y5/00

Abstract:
The present invention provides compositions comprising β-hydroxybutyrate, cyclic or linear β-hydroxybutyrate oligomers, and/or β-hydroxybutyrate ester derivatives, or pharmaceutically-acceptable salts thereof. In various embodiments, the compositions are encapsulated by nanoparticles, such as nanoparticles comprising, e.g., poly(lactic-co-glycolic acid). In additional embodiments, the invention provides methods of using such compositions to induce intestinal stem cell regeneration and/or treat radiation-induced intestinal damage in a subject.
Public/Granted literature
- US20200147018A1 COMPOSITIONS AND METHODS FOR INDUCING INTESTINAL STEM CELL REGENERATION Public/Granted day:2020-05-14
Information query
IPC分类: